Background Gabapentin is commonly used to treat neuropathic pain (pain due to nerve
damage). This review updates a review published in 2014, and previous reviews published …

Background This review is an update of a review published in 2011, itself a major update of
previous reviews published in 2005 and 2000, investigating the effects of gabapentin in …

Cancer-related neuropathic pain is common; it can be disease related or related to the acute
or chronic effects of cancer treatment. For example, chemotherapy-induced peripheral …

Background Pharmacotherapy remains an important modality for the treatment of
neuropathic pain. However, as monotherapy current drugs are associated with limited …

Gabapentin is an anti-epileptic agent but now it is also recommended as first line agent in
neuropathic pain, particularly in diabetic neuropathy and post herpetic neuralgia. α2δ-1, an …

Neuropathic cancer pain (NCP), commonly encountered in clinical practice, may be cancer‐
related, namely resulting from nervous system tumor invasion, surgical nerve damage …

Background: Combining antidepressant or antiepileptic drugs with opioids has resulted in
increased pain relief when used for neuropathic pain in non-cancer conditions. However …

Neuropathic pain is a debilitating chronic condition that remains very difficult to treat.
Recently, a number of clinical studies have compared the effectiveness of combination drug …

Chronic neuropathic pain (NP) is an increasingly prevalent disease and leading cause of
disability which is challenging to treat. Several distinct classes of drugs are currently used for …

Abstract Introduction Aldehyde dehydrogenase 1A3 (ALDH1A3) is a cancer stem cell (CSC)
marker and in breast cancer it is associated with triple-negative/basal-like subtypes and …